The histone deacetylase inhibitor ITF2357 decreases surface CXCR4 and CCR5 expression on CD4(+) T-cells and monocytes and is superior to valproic acid for latent HIV-1 expression in vitro
组蛋白去乙酰化酶抑制剂 ITF2357 可降低 CD4(+) T 细胞和单核细胞表面 CXCR4 和 CCR5 的表达，在体外抑制潜伏 HIV-1 表达方面优于丙戊酸
期刊:Jaids-Journal of Acquired Immune Deficiency Syndromes
影响因子:2.9
doi:10.1097/QAI.0b013e3181d3dca3
Shay Matalon, Brent E Palmer, Marcel F Nold, Antonio Furlan, Afework Kassu, Gianluca Fossati, Paolo Mascagni, Charles A Dinarello
